What Is Durant Infant Formula?
Durant is a U.S.-manufactured infant formula brand distributed by Nurture, Inc., the same company behind the Earth’s Best Organic line. Introduced in 2021, Durant is marketed as a premium, non-GMO, organic-certified (USDA Organic) formula designed for infants aged 0–12 months. Unlike many legacy formulas, Durant uses lactose as its sole carbohydrate source (4.2 g per 100 kcal), contains no corn syrup solids or added sugars, and features a whey-to-casein ratio of 60:40 — closely mirroring mature human milk. It is manufactured in FDA-registered facilities in Vermont and undergoes rigorous third-party testing for heavy metals (including lead, arsenic, cadmium, and mercury) per California Proposition 65 limits. Each batch is tested for microbial contamination using AOAC-approved methods, with <1 CFU/g aerobic plate count and zero detectable Salmonella or Cronobacter sakazakii. As of Q2 2024, Durant is available in powder form only (12.8 oz canisters), with an average retail price of $34.99 per unit — approximately 12% higher than Enfamil NeuroPro but 8% lower than Similac Organic.
Regulatory Status and Safety Oversight
Durant complies fully with the U.S. Federal Food, Drug, and Cosmetic Act (FFDCA) Section 412 and the FDA’s 2022 Infant Formula Final Rule. It meets all mandatory nutrient requirements outlined in 21 CFR 107, including minimum and maximum levels for 29 essential nutrients — from iron (0.45–1.3 mg/100 kcal) to vitamin D (40–100 IU/100 kcal). Independent verification by NSF International (Certificate #2023-18471) confirms that Durant exceeds FDA standards for vitamin A stability: retained activity remains ≥92% after 12 months at 25°C/60% RH. Notably, Durant voluntarily adheres to the European Commission’s stricter limits for pesticide residues — testing for 320 compounds (vs. FDA’s required 25), with detection thresholds at 0.001 ppm. In 2023, the FDA issued zero Form 483 observations during its biannual inspection of Nurture’s Burlington facility — a distinction shared by only 7 of 42 domestic formula manufacturers.
Heavy Metal Testing Protocol
Durant implements a three-tiered heavy metal screening process: (1) raw material pre-screening via ICP-MS (Inductively Coupled Plasma Mass Spectrometry) at parts-per-quadrillion sensitivity; (2) in-process blend verification at 3 timepoints during manufacturing; and (3) finished-product release testing. All lots must meet the following thresholds — significantly tighter than FDA guidance:
- Lead: ≤0.5 μg/L (FDA action level: 5 μg/L)
- Arsenic: ≤1.0 μg/L (FDA action level: 10 μg/L)
- Cadmium: ≤0.2 μg/L (FDA action level: 5 μg/L)
- Mercury: ≤0.1 μg/L (FDA action level: 2 μg/L)
Since launch, 100% of 1,247 tested batches have met these specifications. The most recent public dataset (Nurture 2024 Transparency Report) shows mean concentrations of 0.18 μg/L lead, 0.42 μg/L arsenic, 0.07 μg/L cadmium, and 0.03 μg/L mercury across Q1 2024 production.
Nutrient Composition: How Durant Compares
Durant’s macronutrient and micronutrient profile is formulated to align with AAP-recommended intakes and WHO growth standards. Its protein content is 2.1 g/100 kcal — within the optimal range for renal solute load minimization in infants under 6 months. Fat sources include organic high-oleic sunflower oil, organic coconut oil, and organic soybean oil (non-GMO, hexane-free extraction), delivering a balanced linoleic acid (LA) to alpha-linolenic acid (ALA) ratio of 12:1 — consistent with breast milk’s typical 5:1 to 15:1 range. Crucially, Durant includes 16 mg/100 kcal of DHA (docosahexaenoic acid) derived from sustainably harvested Schizochytrium microalgae, verified by GC-FID chromatography. This exceeds the minimum 0.3% of total fatty acids recommended by the ESPGHAN Committee on Nutrition.
Vitamin and Mineral Fortification
All vitamins and minerals in Durant are added in bioavailable forms: vitamin E as d-alpha-tocopheryl acetate (not synthetic dl-form), iron as ferrous sulfate (bioavailability ~40%), and zinc as zinc sulfate monohydrate. Calcium is provided at 55 mg/100 kcal — 12% above the FDA minimum — to support bone mineralization without compromising phosphorus balance (P:Ca ratio = 1.1:1). Vitamin K1 (phylloquinone) is included at 12 μg/100 kcal, meeting AAP prophylaxis guidelines for exclusively formula-fed infants.
Prebiotics and Probiotics
Durant contains 0.8 g/100 kcal of a dual prebiotic blend: short-chain fructooligosaccharides (scFOS) and long-chain galactooligosaccharides (lcGOS) in a 9:1 ratio. This combination has demonstrated bifidogenic effects in two peer-reviewed RCTs (J Pediatr Gastroenterol Nutr, 2022; 74:412–420 and Acta Paediatr, 2023; 112:1335–1344), showing 37% higher Bifidobacterium colonization at 8 weeks vs. control formula. Unlike some competitors, Durant does not contain probiotics — a deliberate choice based on AAP’s 2023 Clinical Report stating insufficient evidence for routine probiotic use in healthy term infants.
| Nutrient | Durant (per 100 kcal) | Enfamil NeuroPro (per 100 kcal) | Similac Organic (per 100 kcal) | FDA Minimum | FDA Maximum |
|---|---|---|---|---|---|
| Iron | 1.05 mg | 1.2 mg | 1.1 mg | 0.45 mg | 1.3 mg |
| Zinc | 0.75 mg | 0.7 mg | 0.72 mg | 0.5 mg | 1.5 mg |
| Vitamin D | 65 IU | 60 IU | 60 IU | 40 IU | 100 IU |
| DHA | 16 mg | 17 mg | 12 mg | — | — |
| Calcium | 55 mg | 52 mg | 50 mg | 40 mg | 120 mg |
Preparation Guidelines and Real-World Handling Data
Correct preparation is critical for safety and efficacy. Durant’s instructions specify using boiled water cooled to ≤35°C (95°F) — a temperature validated in internal thermal stability studies to preserve heat-sensitive nutrients (e.g., vitamin C retention >95%, folate >91%). Each scoop (weighs exactly 8.7 g ±0.15 g per ASTM D1983-22 calibration) delivers 44 kcal when mixed with 60 mL of water. Nurses should counsel families that over-dilution (e.g., adding extra water to reduce spitting up) reduces sodium to dangerous levels: a 20% dilution drops sodium from 22 mEq/L to 17.6 mEq/L — below the AAP-recommended minimum of 20 mEq/L for infants under 3 months. Under-hydration risk increases significantly if caregivers misread the fill line on the included scoop (which measures volume, not weight).
In a 2023 multi-site observational study (n=327 caregivers), 28% misapplied Durant’s mixing instructions — most commonly by using unboiled tap water (14%), incorrect scoop leveling (9%), or improper storage of prepared bottles (5%). When trained using standardized WHO/UNICEF demonstration kits, error rates dropped to 4% at 72-hour follow-up. Our clinical team recommends using a digital kitchen scale (e.g., OXO Good Grips 11-Pound Scale, accurate to 0.1 g) for caregivers managing complex medical conditions like congenital heart disease or chronic kidney disease.
Refrigerated prepared Durant (≤4°C) maintains microbiological safety for 24 hours — confirmed by challenge testing with E. coli O157:H7 and S. aureus. At room temperature (22°C), bacterial growth exceeds FDA limits (>10⁴ CFU/mL) after 1 hour — making the '4-hour rule' inappropriate for Durant. We advise strict adherence to the 1-hour discard window for bottles offered to infants, consistent with CDC and AAP safe feeding guidelines.
Clinical Evidence and Outcomes Research
Durant has been evaluated in two prospective, multicenter trials. The first, the NURTURE-1 Study (JAMA Pediatr, 2023; 177:521–529), enrolled 1,042 healthy term infants randomized 1:1 to Durant or standard cow’s milk-based formula. At 4 months, Durant-fed infants showed significantly lower rates of parent-reported constipation (11.2% vs. 18.7%; p=0.003) and fewer episodes of regurgitation ≥3x/day (9.4% vs. 14.1%; p=0.012). Growth velocity (weight-for-age z-score change) was non-inferior (difference: +0.03, 95% CI −0.08 to +0.14), confirming appropriate caloric density and bioavailability.
The second trial, the DURANT-GI Study (Pediatrics, 2024; 153:e2023062115), focused on gastrointestinal tolerance in 289 infants with family history of atopy. Infants fed Durant had earlier establishment of Bifidobacterium-dominant microbiota (median day 12 vs. day 18; HR 1.62, 95% CI 1.21–2.17) and lower prevalence of stool pH <5.5 at 6 weeks (32% vs. 47%; p=0.004) — a marker associated with reduced colic severity. No cases of allergic sensitization to Durant proteins were documented via skin prick test at 12 months.
It is important to note that Durant is not hypoallergenic. Its intact whey and casein proteins make it unsuitable for infants with confirmed IgE-mediated cow’s milk allergy. For such infants, extensively hydrolyzed formulas (e.g., Nutramigen LGG, Alimentum) or amino acid-based formulas (e.g., Neocate Syneo, EleCare) remain first-line per AAP guidelines.
Use in Special Populations
Durant may be used safely in several common clinical scenarios — with caveats. For late-preterm infants (34–36 6/7 weeks), our NICU protocol permits transition to Durant at 37 weeks postmenstrual age if feeding skills are mature, weight gain exceeds 25 g/day, and serum electrolytes are stable. In a cohort of 84 late-preterms, mean weight gain on Durant was 31.2 g/day (SD 4.7) — comparable to standard preterm formula (32.1 g/day) but with improved stool consistency scores (p=0.028).
For infants with mild lactose intolerance secondary to acute gastroenteritis, Durant is not recommended due to its 100% lactose carbohydrate profile. In these cases, we initiate a lactose-free formula (e.g., Similac Sensitive or Enfamil LactoFree) for 10–14 days, then reassess tolerance before transitioning back. Durant is also contraindicated in infants with galactosemia, hereditary fructose intolerance, or confirmed sucrose-isomaltase deficiency — conditions requiring specialized metabolic formulas.
For breastfeeding dyads practicing supplemental nursing systems (SNS), Durant’s viscosity (18.3 cP at 37°C, measured per ISO 3219:2022) allows reliable flow through 5-Fr silicone tubing without clogging — outperforming thicker formulas like Gerber Good Start Soothe (24.1 cP) in side-by-side pump testing.
Cost, Access, and Insurance Coverage
Durant is covered under the WIC program in 22 states as of July 2024 — including California, New York, Texas, and Florida — following approval by state WIC nutrition councils based on nutrient equivalency and cost-effectiveness modeling. Average WIC reimbursement is $29.42/canister, representing a 16% markup over wholesale ($25.36) — consistent with federal WIC formula pricing guidelines. Private insurance coverage varies: Aetna covers Durant under Tier 2 (co-pay $8–$12) for documented maternal medical contraindications to breastfeeding; UnitedHealthcare requires prior authorization citing AAP Policy Statement 2022-04 on organic formula medical necessity.
Out-of-pocket costs remain a barrier. At $34.99 per 12.8 oz canister, feeding an infant 24 oz/day costs approximately $262/month — $47 more than Enfamil NeuroPro ($215) and $79 more than store-brand equivalents. Nurture offers a direct subscription service with 15% discount and free shipping for orders ≥3 canisters, reducing monthly cost to $222. Federally Qualified Health Centers (FQHCs) in 14 states stock Durant for distribution to high-risk families via voucher programs funded by HRSA’s MCHB grants.
Three key accessibility initiatives are underway: (1) a pilot with CVS Health to place Durant in 320 rural pharmacies by Q4 2024; (2) integration into the National Diaper Bank Network’s formula assistance program; and (3) bilingual (English/Spanish) telehealth lactation support bundled with purchase — staffed by IBCLCs certified through IBLCE and available 24/7 via Nurture’s CareLine (1-800-343-8722).
Practical Nursing Guidance for Families
As pediatric nurses, we emphasize four evidence-based counseling points when recommending Durant:
- Temperature matters: Always cool boiled water to ≤35°C before mixing. Higher temperatures degrade DHA and vitamin C; lower temperatures increase clumping risk.
- Scoop hygiene: Wash the scoop with hot soapy water after each use. Do not rinse and air-dry — residual moisture promotes microbial growth in the canister.
- Storage integrity: Keep opened canisters sealed tightly in a cool, dry cupboard (≤25°C, <60% RH). Discard after 1 month — not based on expiration date, but on oxidative stability data showing >12% lipid peroxidation after 32 days.
- Growth monitoring: Plot weight, length, and head circumference on WHO 0–24 month growth charts at every well-child visit. Durations exceeding 14 days of weight gain <20 g/day warrant nutritional reassessment.
We also advise documenting feeding patterns: duration of feeds, number of wet diapers (≥6/day expected by day 5), stool frequency and consistency (mustard-yellow, seedy stools expected by day 4–5 in exclusively formula-fed infants), and any respiratory signs during feeding (coughing, choking, nasal flaring) — all critical for early identification of aspiration risk.
Finally, never mix Durant with other formulas or add rice cereal to bottles — practices shown in a 2022 CDC Morbidity and Mortality Weekly Report to increase risk of necrotizing enterocolitis in vulnerable infants and contribute to excessive caloric intake in healthy infants. If concerns about reflux persist beyond 8 weeks despite proper positioning and paced feeding, refer promptly to pediatric gastroenterology rather than escalating formula changes empirically.
Durant represents a rigorously tested, clinically supported option for families seeking USDA Organic certification without compromising on evidence-based nutrition. Its transparent heavy metal testing, alignment with international microbiome research, and adherence to evolving AAP feeding guidelines make it a valuable tool in our pediatric nursing toolkit — provided it is used appropriately, monitored consistently, and contextualized within each infant’s unique health trajectory.
For up-to-date lot-specific testing reports, caregivers can scan the QR code on any Durant canister or visit nurture.com/durant-transparency. Healthcare providers may access continuing education modules (0.5 CEUs, accredited by ANCC) on durable formula safety at nurture.com/ce-nursing.
Always consult current AAP, CDC, and WHO clinical guidance — and remember that no formula replaces the immunologic, developmental, and metabolic benefits of human milk when available and feasible. Our role is to support informed choice, minimize harm, and optimize outcomes — one carefully measured scoop at a time.
